NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Clinical Trials Week


Susan Hasty, Publisher
Table of Contents . . . April 13th, 2009
Non-Subscriber - Summaries Only
Related Areas: Other Issues in Clinical Trials Week | Other Publications

Alzheimer Disease - Independent Study Corroborates Prana's Strategy to Treat Alzheimer's Disease Patients.

Atrophy - QuatRx Completes Enrollment of Ophena(TM)(Ospemifene Tablets) Final Pivotal Phase 3 Study in Women with Postmenopausal Vaginal Atrophy

Celsion Corporation - Celsion Announces Promising ThermoDox® Clinical Results in Primary Liver Cancer Were Published in Expert Opinion

Hepatitis C Virus - Pharmasset Initiates First Time in Human Study of PSI-7851 for the Treatment of Hepatitis C (HCV)

Obesity and Diabetes - Dapagliflozin Clinical Trial Results Indicate Improvement In Key Glycemic Measures In Treatment-Naive Type 2 Diabetes Patients

Schizophrenia - Lilly Announces Inconclusive Phase II Study Results for mGlu2/3 at the International Congress on Schizophrenia Research

Angiogenesis - New angiogenesis study findings have been reported by A.D. Norden and colleagues

Breast Cancer - New breast cancer data have been reported by S. Loibl and co-authors

Breast Cancer - Reports from N.U. Lin and co-researchers add new data to research in breast cancer

Breast Cancer - Research data from M. Campone and colleagues update understanding of breast cancer

Cancer - Data on cancer described by A. Tuca et al

Chronic Lymphocytic Leukemia - Researchers at University of Southampton target chronic lymphocytic leukemia

Chronic Myeloid Leukemia - Recent studies by R.M. Stone and co-authors add new data to chronic myeloid leukemia findings

Clinical Trial Research - New data from E. Decullier et al illuminate research in clinical trial research

Colon Cancer - Research conducted at Princess Margaret Hospital has provided new information about colon cancer

Cytomegalovirus - Scientists at Columbus Children's Hospital publish research in cytomegalovirus

Esophageal Cancer - Researchers from University of Amsterdam describe findings in esophageal cancer

Gastric Cancer - Researchers from Chang Gung Memorial Hospital detail new studies and findings in the area of gastric cancer

Gastric Cancer - Study findings from J.M. Brell et al broaden understanding of gastric cancer

Glioma - Researchers from Mayo Clinic publish new studies and findings in the area of glioma

Hepatitis C Virus - New hepatitis C virus study findings reported from University of Florida

Hepatocellular Cancer - New findings in hepatocellular cancer described by J.E. Uhm and co-researchers

Leukemia - New leukemia study findings recently were published by K.E. Herbert and co-researchers

Monoclonal Antibodies - Research from University of Rochester yields new data on monoclonal antibodies

Monoclonal Antibodies - Scientists at National Cancer Institute publish research in monoclonal antibodies

Multiple Sclerosis - New multiple sclerosis research from Northwestern University discussed

Non-Hodgkin Lymphoma - New non-hodgkin lymphoma data have been reported by researchers at Washington University

Peptide Vaccine - Research from University of Pittsburgh in the area of peptide vaccine described

Prostate Cancer - New findings in prostate cancer described by G. Goldner and co-researchers

T-Cell Lymphoma - Scientists at National Cancer Institute publish research in t-cell lymphoma

Vaccines - Study results from State University of New York update understanding of multiple sclerosis

Cancer Vaccines - Scientists at University of Southampton, Cancer Sciences Division discuss research in cancer vaccines

Pancreatic Cancer Therapy - Research on pancreatic cancer therapy published by scientists at University of Regensburg, Department of Internal Medicine I

A.P. Pharma, Inc. - A.P. Pharma Announces Fourth Quarter and Year-End 2008 Financial Results and Provides Update on APF530 NDA

Addiction Medicine - Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2008 Financial Results

Affymax, Inc. - Affymax Reports Phase 2 Sub-Analysis of Hematide™ in Hemodialysis Patients

Altea Therapeutics - Altea Therapeutics Announces Development and Commercialization Agreement with Amylin and Lilly for an Investigational Transdermal Exenatide

American Association of Colleges of Pharmacy AACP - University of Tennessee Educator Honored for Research Excellence

Angiogenesis - Nereus Pharmaceuticals Initiates Advance, a Randomized Phase 2 Clinical Trial of NPI-2358 in Non-Small Cell Lung Cancer

Archemix Corp. - Archemix Initiates Phase 2a for Lead Aptamer Product Candidate ARC1779

Biotech Business - NanoTox® Continues to Attract Dynamic Leaders with Addition of La Jolla Capital Partners CEO, C. Richard Piazza, to Board of Directors

Biotechnology Business - BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2008 Financial Results

Biovail Corporation - Biovail Announces Establishment of External Advisory Board

Bipolar Disorder - Repligen Licenses Patent Rights for Treatment of Bipolar Disorder

Cubist Pharmaceuticals, Inc. - Cubist Pharmaceuticals Initiates Phase 2 Trial for Therapy to Reduce Blood Loss During Surgery

ExonHit Therapeutics - EXONHIT Expands Neurological Research Activities to Epilepsy

Genzyme Corporation - Genzyme and Bayer HealthCare Enter New Strategic Agreement

Heart Attack - Amorcyte Reports Phase I Results of AMR-001 to Improve Recovery From Severe Heart Attack at ACC Annual Scientific Session

Heart Attack - Heart Hospital of Austin First Site in World to Test Efficacy of New Adult Stem Cell Therapy to Treat Damaged Heart Tissue in Phase II Trial

Heart Failure - Results From Study Show Promising Efficacy and Safety Results for Corthera's Relaxin in Acute Heart Failure

KAI Pharmaceuticals, Inc. - KAI Pharmaceuticals Expands KAI-1678 Development Program, Initiating a Phase 2a Study for Neuropathic Pain

Lantheus Medical Imaging, Inc. - Lantheus Medical Imaging Presents Phase I Study Results of Novel PET Myocardial Perfusion Imaging Tracer at ACC

Medgenics, Inc. - Medgenics’ Phase I/II Clinical Trial Now Shows EPODURE Continuous Anemia Treatment Lasting 5 Months in Kidney Disease Patients

Northwestern University - Adult stem cell injections may reduce pain and improve walking in severe angina patients

Obesity - Orexigen(R) Therapeutics Names Michael Narachi, 24-Year Biopharmaceutical Veteran, New President and Chief Executive Officer

Pharmaceuticals - BrainCells Inc. Appoints Philip Jochelson, M.D. Chief Medical Officer and Jason Levin Chief Business Officer

Pro-Pharmaceuticals, Inc. - Pro-Pharmaceuticals Reports Full Year and Fourth Quarter 2008 Financial Results

SARcode Corporation - SARcode Announces Results of Phase 1 Trial of SAR 1118 Ophthalmic Solution in Healthy Adult Subjects

Seattle Genetics, Inc. - Seattle Genetics Receives FDA Fast Track Designation for SGN-35 for the Treatment of Hodgkin Lymphoma

TCA Cellular Therapy - Combination Adult Stem Cell Therapy Improves Severe Limb Ischemia

Tyrogenex, Inc. - Tyrogenex Inc. to Present at BIO National Venture Conference 2009

Urea Cycle Disorders - Hyperion Therapeutics Announces Results for Phase II Study in Urea Cycle Disorders



Return to Top of Page

-----------------------
PR Login